Sign Out
Hypercholesterolaemia and hypertriglyceridaemia alone or combined (types IIa, IIb, IV dyslipidaemias, as well as types III and V dyslipidaemias although only a few patients have been treated during clinical trials) in patients unresponsive to dietary and other non-drug therapeutic measure (e.g. weight reduction or increased physical activity), particularly when there is evidence of associated risk factors.
The treatment of secondary hyperlipoproteinaemias is indicated if the hyperlipoproteinaemia persists despite effective treatment of the underlying disease (e.g. dyslipidaemia in diabetes mellitus).
Dietary measures initiated before therapy should be continued.
